Taiwan: Taiwan does not recognise a deposit made in an international depositary

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Taiwan: Taiwan does not recognise a deposit made in an international depositary

As Taiwan is not a signatory to the Budapest Treaty, the effect of a deposit made in an international depositary under the Budapest Treaty is generally not recognised in Taiwan. Accordingly, even though a biological material has been deposited in an international depositary in order to meet the enabling requirement, the applicant is still required to make a corresponding deposit in a domestic depositary designated by the Taiwan Intellectual Property Office (TIPO). A late deposit will be deemed valid only if the certificates of deposit issued by both the international and domestic depositaries are filed before a statutory deadline, i.e. within four months from the filing date or sixteen months from the earliest priority date claimed, whichever is applicable. Further, in the event that a deposit is deemed invalid, the applicant may file a request for reinstatement of the deposit procedure within thirty days from the day following the cessation of the cause for delay.

For a patent application filed on December 29 2015 in Taiwan claiming the priority date of February 29 2014 from the counterpart US application with a deposit of biological material, the applicant needed to make a corresponding deposit at the domestic depositary to fulfil the enabling requirement. Accordingly, the applicant completed the necessary forms and submitted to the depositary the forms in which it was indicated that six vials of bacterial, i.e. the relevant biological material, are to be deposited in accordance with the Rules for Depositing Biological Materials. Upon perusal, the depositary suggested that a total of 25, instead of six vials, of bacteria be deposited. Thus, the applicant proceeded to make arrangements for the preparation of 19 additional vials of the bacteria on an urgent basis, but missed the four-month statutory deadline for filing with TIPO the certificates of deposit issued by an international depositary and the domestic depositary. The applicant then filed a request for reinstatement of the deposit procedure; however, the request was not entertained by TIPO. Against this unfavourable result, the applicant filed an appeal and, in turn, pursued the subsequent administrative litigation procedures.

The applicant argued that since it is time-consuming to prepare 19 additional vials of the bacteria to comply with the depositary's suggestion, he took it for granted that he could wait until the certificate of the deposit of all the 25 vials of the bacteria was available to file both the international and domestic certificates in a lump. The applicant also claimed that he had exercised all due diligence in complying with the depositary's suggestion, and the occurrence of the delay is not an event controllable and attributable to him.

On April 25 2019, the Supreme Administrative Court issued a final judgment upholding TIPO's decision that the deposit is invalid and cannot be reinstated as requested by the applicant. In its judgment, the Supreme Administrative Court interpreted "factors not attributable to the applicant" in a strict manner, indicating that only an event substantially corresponding to "the will of God" or "war" can be considered as a factor not attributable to the applicant. On top of this, the court held that the applicant should have at least deposited six vials of the bacteria in accordance with the Rules for Depositing Biological Materials and filed the international certificate of deposit in a timely manner.

This case suggests that inadvertent negligence might result in irreparable loss to the applicant. A patent practitioner should do his utmost to ensure that a patent application takes every required step towards becoming a patent and give sound advice to his clients when a patent practice in Taiwan is not in harmony with international practice.

lin.jpg

Ming-yeh Lin


Saint Island International Patent & Law Offices7th Floor, No. 248, Section 3Nanking East RoadTaipei 105-45, Taiwan, ROCTel: +886 2 2775 1823Fax: +886 2 2731 6377siiplo@mail.saint-island.com.twwww.saint-island.com.tw

more from across site and SHARED ros bottom lb

More from across our site

By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions
This year’s IP STARS Americas rankings reveal that firms are expanding their capabilities, particularly in trade secrets and life sciences
Law firms’ expanding IP capabilities are driving broader industry recognition across a wider range of practice areas
As specialist boutiques challenge traditional firm models, major disputes involving Disney, Ericsson, Siemens and Dolby highlight the firms winning work before the UPC
The firm has added two leading damages specialists as it expands beyond technical analysis and deepens its role in the economics of IP litigation
Josh Seidenfeld, partner at DLA Piper, outlines the emerging legal trends that drive the future of life sciences innovation and how stakeholders can prepare for the future
South Korea's One Law Partners is combining with boutique firm Minwho Law Group to leverage global expansion of K-content and build a broader offering spanning IP, tech and regulatory advisory work
Russell Kennedy's Gina Tresidder on juggling matters, delivering hard truths, and why IP ownership is rarely as simple as people think
Attorney Oran Friar and trainee attorney Harry Cunliffe at Reddie & Grose, share that patent filings for clinical LLMs are surging, but success in the UK and Europe hinges on demonstrating technical innovation
Implementers can use the UK courts to seek FRAND terms for patent pool licences
Gift this article